ÂÜÀòÂÒÂ×

Aiden Aceves, Ph.D., currently serves as a Board Observer at 858 Therapeutics, Superluminal Medicines Inc., Profluent Bio, Capacity Bio, DEM Biopharma, Inc., and Switch Therapeutics, while holding the position of Board Director at Basking Biosciences Inc., Cirsium Biosciences, and Stealth RNA Biotech Company. With a Doctor of Philosophy in Bioengineering from Caltech, obtained from 2017 to 2021, and a Bachelor's Degree in Chemistry from the University of California, Riverside, Aiden Aceves combines advanced education with extensive experience in biopharmaceutical board governance.